CKD-828

DRUG4 trials

Sponsors

Chong Kun Dang Pharmaceutical

Conditions

DyslipidemiasHypertension

Phase 1

CKD-828 (40/5mg) Pharmacokinetic Study

CompletedNCT01340131

Chong Kun Dang PharmaceuticalHypertension

Start: 2011-01-31End: 2011-04-30Updated: 2011-04-28

CKD-828 (80/5mg) Pharmacokinetic Study

CompletedNCT02250833

Chong Kun Dang PharmaceuticalHypertension

Start: 2014-09-30End: 2014-12-31Updated: 2015-04-10

CKD-828 (80/5mg) Pharmacokinetic Study

CompletedNCT02358824

Chong Kun Dang PharmaceuticalHypertension

Start: 2015-02-28End: 2015-06-30Updated: 2015-07-08

Phase 3

Clinical Study to Evaluate the Efficacy and Safety of CKD-348(CKD-828, D326, D337) Tablet

Chong Kun Dang PharmaceuticalDyslipidemias, Hypertension

Start: 2019-10-23End: 2021-04-30Target: 120Updated: 2020-05-14